Asbestos plaques in a typical veteran's hospital population

Miller, Jeffrey A.; Zurlo, John V.

doi:10.1002/(sici)1097-0274(199612)30:6<726::aid-ajim9>3.3.co;2-x

Cited by 3 publications

(3 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Our no-apparent-exposure group consisted of participants who responded "no" to the exposure pathways listed in the questionnaire and who were likely exposed via ambient air and other pathways not assessed by our screening questionnaire. The rate of 6.7% for the no-apparent-exposure group in our analysis and the rate of 9.1% given by Price in his letter are considerably higher than the prevalence rates of pleural abnormalities found in published studies of other nonoccupationally exposed populations in the United States, which range from 0.2% among bluecollar workers in North Carolina (Castellan et al 1985) to 2.3% among patients at Veterans Affairs hospitals in New Jersey (Miller and Zurlo 1996). Of note, these studies did not exclude family contacts of workers or domestic exposures (Castellan et al 1985;Anderson et al 1979).…”

Section: Radiographic Abnormalitiescontrasting

confidence: 54%

Validation of (Q)SARs models.

Kaiser¹

2004

Environ Health Perspect

View full text Add to dashboard Cite

show abstract

Section: Radiographic Abnormalitiescontrasting

confidence: 54%

Validation of (Q)SARs models.

Kaiser¹

2004

Environ Health Perspect

View full text Add to dashboard Cite

show abstract

“…Their prevalence is most directly related to duration from first exposure; they are rare within less than 20 years. Pleural plaques consistent with asbestos exposure appear in chest films of 2.3% of U.S. males, a percentage that has been remarkably stable both for the general population in the early 1970s and veterans in the 1990s (94,95).…”

Section: Nonmalignant Pleural Abnormalities Associated With Asbestosmentioning

confidence: 98%

Diagnosis and Initial Management of Nonmalignant Diseases Related to Asbestos

2004

Am J Respir Crit Care Med

401

115

View full text Add to dashboard Cite

Asbestos is a general term for a heterogeneous group of hydrated magnesium silicate minerals that have in common a tendency to separate into fibers (1). These fibers, inhaled and displaced by various means to lung tissue, can cause a spectrum of diseases including cancer and disorders related to inflammation and fibrosis. Asbestos has been the largest single cause of occupational cancer in the United States and a significant cause of disease and disability from nonmalignant disease. To this demonstrable burden of asbestos-related disease is added the burden of public concern and fear regarding risk after minimal exposure. This statement presents guidance for the diagnosis of nonmalignant asbestos-related disease. Nonmalignant asbestos-related disease refers to the following conditions: asbestosis, pleural thickening or asbestos-related pleural fibrosis (plaques or diffuse fibrosis), "benign" (nonmalignant) pleural effusion, and airflow obstruction. This document is intended to assist the clinician in making a diagnosis that will be the basis for individual management of the patient. It therefore provides overarching criteria for the diagnosis, specific guidelines for satisfying these criteria, and descriptions of the clinical implications of the diagnosis, including the basic management plan that should be triggered by the diagnosis. It is understood that disease may be present Members of the Ad Hoc Statement Committee have disclosed any direct commercial associations (financial relationships or legal obligations) related to the preparation of this statement. This information is kept on file at the ATS headquarters.

show abstract

“…General population surveys looking for pleural plaques have shown prevalence rates as high as 6.8%. However, most surveys show rates around 2.5% or less and rates have been found as low as 0.21% . Surveys of exposed populations have shown varying rates of pleural plaques, as high as 49% .…”

Section: Discussionmentioning

confidence: 99%